LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_001904.4:c.2175C>T
CTNNB1
· NP_001895.1:p.(Gly725=)
· NM_001904.4
GRCh37: chr3:41280662 C>T
·
GRCh38: chr3:41239171 C>T
Gene:
CTNNB1
Transcript:
NM_001904.4
Final call
VUS
PM2 supporting
Variant details
Gene
CTNNB1
Transcript
NM_001904.4
Protein
NP_001895.1:p.(Gly725=)
gnomAD AF
6.443506556267922e-05 (v4.1)
ClinVar
Likely benign
OncoKB
Unknown Oncogenic Effect
Classification rationale
Interpretation summary
Generated evidence synthesis
1
VUS: PM2 supporting is met because gnomAD v4.1 AF 6.44351e-05 is below 0.0001 with zero homozygotes.
Final determination:
Under the generic ACMG/AMP 2015 fallback, one supporting criterion alone satisfies neither a pathogenic nor a benign combination rule, so the final call is VUS.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: PVS1 requires a null variant (nonsense, frameshift, canonical splice, start-loss or stop-loss), and this is a synonymous variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PS1 | N/A | Not applicable: PS1 requires a missense variant, and this is a synonymous variant. |
generic_acmg_combination_rules
|
| PS2 | Not assessed | Not assessed: parental maternity and paternity confirmation, family history, and proband disease documentation are unavailable. |
|
| PS3 | Not assessed | Not assessed: no variant-specific functional assay or validated damaging-effect measurement was available for CTNNB1 c.2175C>T (p.Gly725=). |
PMID:25741868
|
| PS4 | Not met | Not met: no affected-versus-control counts, matched-ancestry frequency comparison, odds ratio, or confidence interval was available for the exact variant. |
PMID:25741868
clinvar
gnomad_v2
gnomad_v4
|
| PM1 | N/A | Not applicable: PM1 requires a missense variant, and this is a synonymous variant. |
generic_acmg_combination_rules
|
| PM2 | Met | Met at supporting: gnomAD v4.1 AF 6.44351e-05 is below the generic PM2 supporting threshold of <=0.0001, with zero homozygotes. |
gnomad_v2
gnomad_v4
PMID:25741868
|
| PM3 | N/A | Not applicable: CTNNB1-related neurodevelopmental disorder is autosomal dominant, whereas PM3 is limited to recessive disorders with a confirmed pathogenic variant in trans. |
|
| PM4 | N/A | Not applicable: PM4 requires a protein-length change, and this is a synonymous variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PM5 | N/A | Not applicable: PM5 requires a missense variant, and this is a synonymous variant. |
generic_acmg_combination_rules
|
| PM6 | Not assessed | Not assessed: no documented de novo observation exists, and parental testing or maternity/paternity information is unavailable. |
|
| PP1 | Not assessed | Not assessed: affected-relative genotypes, phenotype concordance, and the number of informative meioses are not documented. |
|
| PP2 | N/A | Not applicable: PP2 requires a missense variant, and this is a synonymous variant. |
generic_acmg_combination_rules
|
| PP3 | Not met | Not met: the synonymous variant's required SpliceAI max delta is unavailable, so it cannot reach the PP3 supporting threshold of >=0.2. |
spliceai
|
| PP4 | Not assessed | Not assessed: no patient phenotype or family-history details were available to judge specificity for a single-gene disease. |
|
| PP5 | Not met | Not met: ClinVar has zero expert-panel submissions and the two exact-variant laboratory submissions classify it as Likely benign, not pathogenic. |
clinvar
|
| BA1 | Not met | Not met: gnomAD v4.1 all-comers AF 6.44351e-05 is far below the BA1 threshold of 0.05. |
gnomad_v2
gnomad_v4
PMID:25741868
|
| BS1 | Not met | Not met: the maximum observed AF is 6.44351e-05, well below the generic BS1 default of 0.01 for this early-onset dominant disorder. |
gnomad_v2
gnomad_v4
PMID:25741868
|
| BS2 | Not assessed | Not assessed: gnomAD reports zero homozygotes but provides no individual-level healthy adult observation meeting the BS2 age, inheritance, and penetrance requirements. |
gnomad_v2
gnomad_v4
PMID:25741868
|
| BS3 | Not assessed | Not assessed: no variant-specific functional assay or validated evidence showing no damaging effect on protein function or splicing was available. |
PMID:25741868
|
| BS4 | Not assessed | Not assessed: no affected relatives with documented absence of the variant are reported for evaluating non-segregation. |
|
| BP1 | N/A | Not applicable: BP1 requires a missense variant, and this is a synonymous variant. |
generic_acmg_combination_rules
|
| BP2 | Not assessed | Not assessed: no pathogenic partner allele or parental, offspring, segregation, or molecular phase data establish cis or trans configuration. |
|
| BP3 | N/A | Not applicable: BP3 requires an in-frame indel in a repeat region, and this is a synonymous variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| BP4 | Not met | Not met: the synonymous variant's required SpliceAI max delta is unavailable, so no result can be shown to meet the BP4 threshold of <=0.1. |
spliceai
|
| BP5 | Not assessed | Not assessed: no patient record documents the exact variant together with an alternate molecular basis for the disease. |
|
| BP6 | Not met | Not met: ClinVar reports Likely benign from two clinical laboratories but zero expert-panel submissions, so no qualifying reputable-source benign report is available. |
clinvar
|
| BP7 | Not assessed | Not assessed: BP7 requires no splice impact and low conservation, but SpliceAI and qualifying conservation evidence are unavailable. |
spliceai
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.